Inpefa

Active Ingredient(s): Sotagliflozin
FDA Approved: * May 26, 2023
Pharm Company: * LEXICON PHARMS INC
Category: Heart (Cardiac)
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Inpefa 200 mg Oral Tablet
NDC: 70183-220
Labeler:
Lexicon Pharmaceuticals Inc.
Inpefa 200 mg Oral Tablet
NDC: 70183-221
Labeler:
Lexicon Pharmaceuticals, Inc.
Inpefa 400 mg Oral Tablet
NDC: 70183-240
Labeler:
Lexicon Pharmaceuticals Inc.
Inpefa 400 mg Oral Tablet
NDC: 70183-241
Labeler:
Lexicon Pharmaceuticals, Inc.